EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

This publication has 75 references indexed in Scilit:

• Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
  Supportive Care in Cancer, 2006
• Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
  European Journal Of Cancer, 2005
• Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa
  European Journal Of Cancer, 2005
• M Jones, B Schenkel, J Just, L Fallowfield. Epoetin alfa improves quality of life in patients with cancer: Results of a metaanalysis,Cancer (2004) 101(8) 1720-1732
  Cancer, 2005
• Epoetin‐α during radiotherapy for stage III esophageal carcinoma
  Cancer, 2005
• Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Multicenter German Trial
  The Oncologist, 2005
• EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
  European Journal Of Cancer, 2004
• Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
  Journal of Clinical Oncology, 2004
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
  The Lancet, 2003
• A multicenter study of recombinant human erythropoietin (epoetin α) in the management of anemia in cancer patients receiving chemotherapy
  Anti-Cancer Drugs, 1997